Correction to Health Care Roundup

Features Dow Jones Newswires

Shares of health-care companies rose amid deal speculation.

Continue Reading Below

Tenet HealthCare rallied after The Wall Street Journal reported the hospital chain, one of the most extensive in the U.S., has hired investment banks Lazard and Barclays to help it explore strategic alternatives, including a possible sale.

Shares of Halozyme Therapeutics surged after the biotech company struck a licensing deal with drug maker Bristol-Myers Squibb on a suite of immunotherapy drugs. Bristol is one of the leaders in the emerging area of immunotherapy, which harnesses the body's own defenses in the fight against cancer.

Shares of Array BioPharma fell after the drug developer said it was selling shares in a secondary offering.

Rob Curran, rob.curran@dowjones.com

Corrections & Amplifications

Continue Reading Below

This item was corrected at 6:36 p.m. ET because an earlier version incorrectly attributed information to Tenet rather than a WSJ report. Tenet HealthCare rallied after The Wall Street Journal reported the hospital chain, one of the most extensive in the U.S., has hired investment banks Lazard and Barclays to help it explore strategic alternatives, including a possible sale.

Tenet HealthCare rallied after The Wall Street Journal reported the hospital chain, one of the most extensive in the U.S., has hired investment banks Lazard and Barclays to help it explore strategic alternatives, including a possible sale. "Health Care Higher Amid Deal Speculation -- Health Care Roundup," published at 5:10 p.m. ET, incorrectly attributed the information to Tenet rather than a WSJ report.

(END) Dow Jones Newswires

September 14, 2017 18:51 ET (22:51 GMT)